Covered recipient · General Payments record
LUIS RETAMOZO
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$863.83
- Reported across 44 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $500.16 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $124.54 | 6 |
| Novo Nordisk AS | $117.57 | 7 |
| Abbott Laboratories | $64.68 | 3 |
| PFIZER INC. | $51.67 | 3 |
| Inspire Medical Systems, Inc. | $36.16 | 1 |
| Sumitomo Pharma America, Inc. | $28.13 | 1 |
| Xeris Pharmaceuticals, Inc. | $23.49 | 1 |
| Medtronic, Inc. | $19.28 | 1 |
| Acerta Pharma LLC | $18.65 | 1 |
| Exact Sciences Corporation | $15.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.63 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124825837 | CMS |
| Abbott Laboratories | $18.74 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124825839 | CMS |
| Abbott Laboratories | $25.31 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124825841 | CMS |
| ABBVIE INC. | $18.95 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105939144 | CMS |
| ABBVIE INC. | $19.47 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105939146 | CMS |
| ABBVIE INC. | $16.58 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105939148 | CMS |
| ABBVIE INC. | $26.55 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105939150 | CMS |
| ABBVIE INC. | $20.57 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105939152 | CMS |
| ABBVIE INC. | $22.42 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105939154 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.65 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105540831 | CMS |
| Exact Sciences Corporation | $15.99 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114852108 | CMS |
| Inspire Medical Systems, Inc. | $36.16 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148100854 | CMS |
| Medtronic, Inc. | $19.28 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117052228 | CMS |
| Novo Nordisk Inc | $15.82 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097033950 | CMS |
| Novo Nordisk Inc | $17.95 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097265641 | CMS |
| Novo Nordisk Inc | $17.03 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097398209 | CMS |
| Novo Nordisk Inc | $19.12 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096908079 | CMS |
| Novo Nordisk Inc | $13.12 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097153191 | CMS |
| Novo Nordisk Inc | $17.40 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097704366 | CMS |
| Novo Nordisk Inc | $17.13 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096655424 | CMS |
| PFIZER INC. | $18.79 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130999232 | CMS |
| PFIZER INC. | $14.27 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131265577 | CMS |
| PFIZER INC. | $18.61 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131790367 | CMS |
| Sumitomo Pharma America, Inc. | $28.13 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148909236 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.49 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144603416 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.